Robert E. Gagnon Harvard Bioscience Inc (HBIO) insider trading activity

HBIO Quotes by TradingView

Robert E. Gagnon is Director of HARVARD BIOSCIENCE INC. Currently has a direct ownership of 110,000 shares of HBIO, which is worth approximately $62,699. The most recent transaction as insider was on Jul 16, 2025, when has been sold 110,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
n/a 3M change
n/a 12M change
Total Value Held $62,699

Robert E. Gagnon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 16 2025
BUY
Grant, award, or other acquisition
-
110,000 Added 50.0%
110,000 Common Stock

Also insider at

VSTM
Verastem, Inc. Healthcare
Director
BBLG
Bone Biologics Corp Healthcare
Director
REG

Robert E. Gagnon

Director
Needham, MA

Track Institutional and Insider Activities on HBIO

Follow HARVARD BIOSCIENCE INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HBIO shares.

Notify only if

Insider Trading

Get notified when an Harvard Bioscience Inc insider buys or sells HBIO shares.

Notify only if

News

Receive news related to HARVARD BIOSCIENCE INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HBIO